Shridevi Institute, US-based Vaxonyx sign MoU for AI-driven cancer and genomic research

Shridevi Institute of Medical Sciences in Tumakuru has signed an MoU with Vaxonyx LLC for collaboration. This partnership aims to focus on AI-enabled bioinformatics and genomic research tailored for Indian populations. They will develop personalized cancer therapies by analyzing individual tumor profiles. The collaboration will also explore the creation of genomic datasets to improve genetic models. Moreover, they intend to develop DNA-based vaccine candidates for relevant public health issues.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/nj7thfi
via IFTTT